Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
Ghent University · Université de Montréal · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
62
total citations
- FWCI
- 81.51
- Percentile
- 100%
- References
- 31
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Chronic rhinosinusitis
- Nasal polyps
- Medicine
- Double blind
- Internal medicine
- Surgery
- Placebo
- Alternative medicine
No related works found for this paper.